Eagle Pharmaceuticals, Inc. company information, Employees & Contact Information

Eagle Pharmaceuticals Announces Availability of Unaudited Second Quarter 2025 Financial Statements Yahoo Finance

Q1 2025 Unaudited Financials — Eagle Pharmaceuticals posts statements and investor materials available now Stock Titan

Eagle Pharmaceuticals to Appoint Abhinav Jain to its Board of Directors citybiz

Eagle Pharmaceuticals Announces Availability of Proxy Materials and Audited Financial Statements for the 2023 and 2024 Fiscal Years The Manila Times

Annual Meeting Alert: Eagle Pharmaceuticals Releases Two Years of Audited Financials Ahead of October Meeting Stock Titan

Pemfexy, a Ready-to-Dilute Formulation of Pemetrexed, Gets Final FDA Approval Medical Professionals Reference

Eagle Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference FinancialContent

Eagle Pharmaceuticals Appoints Debra M. Hussain as SVP citybiz

Eagle Pharmaceuticals to Host Second Quarter 2023 Financial Results on August 8, 2023 Yahoo Finance

Eagle Pharmaceuticals to Present at Two Upcoming Healthcare Conferences Stock Titan

Eagle Pharmaceuticals Completes Acquisition of Acacia Pharma Group citybiz

Eagle Announces Update on Delisting from Nasdaq and SEC Deregistration Yahoo Finance

Eagle Pharmaceuticals CEO and Founder Scott Tarriff Retires citybiz

Eagle Pharmaceuticals Granted Unique J-Code and Pass-Through Status for BARHEMSYS® from CMS Yahoo Finance

Eagle Pharmaceuticals Appoints Christopher Krawtschuk as Chief Financial Officer Yahoo Finance

Eagle Pharmaceuticals to Present Abstract on Post-hoc Analysis of Amisulpride at the 77th PGA (PostGraduate Assembly in Anesthesiology) in New York City Yahoo Finance

Eagle Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq Yahoo Finance

Eagle Pharmaceuticals Receives FDA Qualified Infectious Disease Product (QIDP) and Fast-Track Designation for CAL02, Providing Five-Year Exclusivity Extension Yahoo Finance

Eagle Pharmaceuticals Announces First Patient Randomized in Phase 2 Study Evaluating CAL02, a Novel First-in-Class Anti-Toxin Drug Candidate, in Severe Community-Acquired Bacterial Pneumonia (SCABP) Yahoo Finance

TailorMed Partners with Eagle Pharmaceuticals to Streamline Patient Financial Assistance Enrollment The AI Journal

Eagle Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq Stock Titan

Eagle Pharmaceuticals Reaches Settlement Agreement with GlobeNewswire

Biotech IP Monetization Platforms Market Size, Report by 2034 Precedence Research

Eagle Pharmaceuticals to Complete Nasdaq Delisting After Trading Suspension Stock Titan

Eagle Pharmaceuticals’ Investor Day to Focus on Acute Care Products and Pipeline Programs; Tuesday, December 6, 2022, at 8:00am ET at the Lotte New York Palace (2022-12-01) Seeking Alpha

Eagle Pharmaceuticals Agrees to Terms to Acquire Acacia Pharma Group plc GlobeNewswire

Eagle Pharmaceuticals to Present at the 2021 RBC Capital Markets Global Healthcare Conference FinancialContent

Eagle Pharmaceuticals Announces Submission of New Drug GlobeNewswire

Eagle Pharmaceuticals Takes Equity Stake in, with Option to GlobeNewswire

Reminder: Eagle Pharmaceuticals to Host CAL02 Investor Event on September 9, 2021 | User | custercountychief.com FinancialContent

Eagle Pharmaceuticals Announces Results of 2025 Annual Meeting of Stockholders The Manila Times

Eagle Pharmaceuticals Announces Commercial Availability of PEMFEXY™ Business Wire

FDA Approves Non-Alcohol Formula of Docetaxel Injection Medical Professionals Reference

New Pemetrexed Formulation to Be Reviewed by FDA Medical Professionals Reference

FDA grants fast track designation to Ryanodex for treatment of exertional heat stroke Medical Design & Outsourcing

About Us FinancialContent

FDA Grants Seven Years’ Market Exclusivity to Eagle Pharmaceuticals’ Ryanodex for the Treatment of Malignant Hyperthermia NTB Kommunikasjon